Recent News

• 02.10.2026 - Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
• 01.29.2026 - Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
• 01.26.2026 - CoaW27941
• 01.26.2026 - CoaW27942
• 01.26.2026 - CoaW27940
• 01.26.2026 - CoaW27943
• 01.26.2026 - CoaW27941NC
• 01.26.2026 - CoaW27929NC
• 01.26.2026 - W27941 CoA
• 01.26.2026 - CoaW27938

Recent Filings

• 02.10.2026 - 8-K Current report
• 02.10.2026 - EX-99.1 EX-99.1
• 02.09.2026 - EFFECT Notice of Effectiveness
• 02.09.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.30.2026 - DEF 14A Other definitive proxy statements
• 01.30.2026 - S-3 Registration statement under Securities Act of 1933
• 01.29.2026 - EX-99.1 EX-99.1
• 01.29.2026 - 8-K Current report